| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/24/2013 | US20130023526 Isoxazolines as Therapeutic Agents |
| 01/24/2013 | US20130023518 Novel 3,3-dimethyl tetrahydroquinoline derivatives |
| 01/24/2013 | US20130023515 Novel spiropiperidine prolylcarboxypeptidase inhibitors |
| 01/24/2013 | US20130023513 Methods and Compositions for Treating Cardiovascular Disorders |
| 01/24/2013 | US20130023504 Modulation of Prostaglandin/Cyclooxygenase Metabolic Pathways |
| 01/24/2013 | US20130023503 Nk1 antagonists |
| 01/24/2013 | US20130023495 Uses of dgat1 inhibitors |
| 01/24/2013 | US20130023494 Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| 01/24/2013 | US20130023491 Beta-cell replication promoting compounds and methods of their use |
| 01/24/2013 | US20130023489 Compositions and methods for preventing and treating diseases and environmentally induced health disorders |
| 01/24/2013 | US20130023488 Methods and compounds for reducing intracellular lipid storage |
| 01/24/2013 | US20130023486 Phenyl c-glucoside derivatives, preparation methods and uses thereof |
| 01/24/2013 | US20130023483 Template-fixed peptidomimetics with cxcr7 modulating activity |
| 01/24/2013 | US20130023474 Compositions, uses and methods for treatment of metabolic disorders and diseases |
| 01/24/2013 | US20130023472 Ldl quantitation and method of use |
| 01/24/2013 | US20130023471 Methods to restore glycemic control |
| 01/24/2013 | US20130023470 Exendin and exendin agonists for eating disorders |
| 01/24/2013 | US20130023468 Liquid enteral nutritional composition suitable for tube feeding, minimizing lower and upper tract digestive conditions |
| 01/24/2013 | US20130023467 Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients |
| 01/24/2013 | US20130023466 Peptide YY and Peptide YY Agonists for Treatment of Metabolic Disorders |
| 01/24/2013 | US20130023465 Use of Human Chorionic Gonadotropin (hCG) by Oral-Sublingual or Injectable Route as an Appetite-Suppressant Agent. |
| 01/24/2013 | US20130023464 Novel compounds and their effects on feeding behaviour |
| 01/24/2013 | US20130022690 Pharmaceutical composition and method for reducing weight |
| 01/24/2013 | US20130022679 Controlled Release and Taste Masking Oral Pharmaceutical Composition |
| 01/24/2013 | US20130022673 Enhancement of magnesium uptake in mammals |
| 01/24/2013 | US20130022671 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 01/24/2013 | US20130022663 Method of making and using a topical medicated formula and delivery system to use to prevent and treat breast diseases and breast cancer as well as use as skin wellness and anti-wrinkle formula |
| 01/24/2013 | US20130022644 Novel n-phenylacetamide derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 01/24/2013 | US20130022642 Dual Antagonist for TNF-A and IL-21 for Preventing and Treating Autoimmune Diseases |
| 01/24/2013 | US20130022634 New composition and methods for treatment of autoimmune and allergic diseases |
| 01/24/2013 | US20130022630 Method for treating amyloid disease |
| 01/24/2013 | US20130022620 Assays and methods pertaining to pre-amyloid intermediates |
| 01/24/2013 | US20130022610 Methods of decreasing glycosylated hemoglobin in patients with dyslipidemia |
| 01/24/2013 | US20130022592 Continuous subcutaneous insulin infusion methods with a hyaluronan-degrading enzyme |
| 01/24/2013 | US20130022588 Stable formulations of a hyaluronan-degrading enzyme related applications |
| 01/24/2013 | US20130022587 Cycloalkyl-Substituted Imidazole Derivative |
| 01/24/2013 | US20130022570 Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrants |
| 01/24/2013 | US20130020226 Product for parenteral nutrition of obese intensive-care patients |
| 01/24/2013 | CA2842352A1 3-(fluorvinyl)pyrazoles and the use thereof |
| 01/24/2013 | CA2842015A1 Imino-sugar c-glycosides, preparation and use thereof |
| 01/24/2013 | CA2841955A1 Botulinum toxins for use in a method for treatment of adipose deposits |
| 01/24/2013 | CA2841906A1 Azabenzimidazole derivative having ampk-activating activity |
| 01/24/2013 | CA2841899A1 Btk inhibitors |
| 01/24/2013 | CA2841757A1 Gpr 119 modulators |
| 01/24/2013 | CA2841645A1 Azetidine derivatives for treatment of melanin related disorders |
| 01/24/2013 | CA2840284A1 Fungicidal alkyl-substituted 2-[2-chloro-4-(4-chloro-phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds |
| 01/23/2013 | EP2548874A2 Substituted piperazines as CB1 antagonists |
| 01/23/2013 | EP2548618A2 Organic compounds |
| 01/23/2013 | EP2548570A1 Pharmaceutical composition for treating a metabolic syndrome |
| 01/23/2013 | EP2548565A2 Pharmaceutical composition for treating diabetes containing quamoclit angulata extracts |
| 01/23/2013 | EP2548564A1 Pharmaceutical agent, nutrition for a patient and weight reduction method |
| 01/23/2013 | EP2548453A1 High-potency sweetener for hydration and sweetened hydration composition |
| 01/23/2013 | EP2547679A1 2,3 dihydro-1h-inden-1-yl- 2,7-diazaspiro [3.6]nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor |
| 01/23/2013 | EP2547343A2 Use of p2x purinergic receptor agonists to enhance insulin secretion in pancreatic beta cells |
| 01/23/2013 | EP2547339A1 Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions |
| 01/23/2013 | EP2547221A2 Fat-binding compositions |
| 01/23/2013 | CN1606545B Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/23/2013 | CN102892761A 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists |
| 01/23/2013 | CN102892423A Adiponectin production accelerating composition |
| 01/23/2013 | CN102892421A Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders |
| 01/23/2013 | CN102892414A Carotenoid-containing composition and production method therefor |
| 01/23/2013 | CN102892310A Fat-binding compositions |
| 01/23/2013 | CN102892309A Low protein infant formula with increased essential amino acids |
| 01/23/2013 | CN102887836A L-phenylglycine derivative and application thereof |
| 01/23/2013 | CN102886038A Traditional Chinese medicine preparation for losing weight and preparation method of traditional Chinese medicine preparation |
| 01/23/2013 | CN102886024A Composition with function of aiding to reduce blood fat and preparation method of composition |
| 01/23/2013 | CN102886019A Traditional Chinese medicinal blood sugar reducing plaster |
| 01/23/2013 | CN102885975A Traditional Chinese medicine composition for treating diabetes mellitus |
| 01/23/2013 | CN102885972A Chinese medicinal composition for reducing blood pressure and application method thereof |
| 01/23/2013 | CN102885937A Preparation method and application of morelberry effective fractions |
| 01/23/2013 | CN102885923A Preparation method of slimming drug |
| 01/23/2013 | CN102885922A Preparation method of slimming drug |
| 01/23/2013 | CN102885921A Slimming Chinese medicine composition |
| 01/23/2013 | CN102885920A Slimming Chinese medicine preparation composition |
| 01/23/2013 | CN102885919A Preparation of slimming drug |
| 01/23/2013 | CN102885918A Preparation method of slimming Chinese medicine preparation |
| 01/23/2013 | CN102885900A Composite with weight loss function and preparation method of composite |
| 01/23/2013 | CN102885897A Composition having auxiliary blood sugar level reducing function and method for preparing same |
| 01/23/2013 | CN102885863A Flavone hippophae composition and application of composition |
| 01/23/2013 | CN102885854A Taiwanese green propolis extractants used for the purpose of slowing down progression of disease of patient |
| 01/23/2013 | CN102885847A Novel uses of camellia oleifera cake polysaccharide |
| 01/23/2013 | CN102885797A Composition containing pravastatin calcium as well as preparation method and application thereof |
| 01/23/2013 | CN102885780A Method for improving bioavailability of resveratrol |
| 01/23/2013 | CN102885779A Preparation method of 1-deoxynojirimycin sustained-release pellets |
| 01/23/2013 | CN102885771A High-concentration vitamin C injection solution and preparation method thereof |
| 01/23/2013 | CN102885306A Health-care food composite with function of assisting in reducing blood fat and preparation method thereof |
| 01/23/2013 | CN102885291A Tricholoma-matsutake chewing tablet and preparation method thereof |
| 01/23/2013 | CN102885054A Sterilization composition containing prothioconazole and prothioconazole |
| 01/23/2013 | CN102429851B Blood-circulation-promoting, weight-reducing and fat-lowering bath vinegar combining vinegar and traditional Chinese medicines and preparation method thereof |
| 01/23/2013 | CN102327238B Levocarnitine composition for injection and preparation method of levocarnitine composition |
| 01/23/2013 | CN102309452B Fluvastatin sodium liposome solid preparation |
| 01/23/2013 | CN102293895B Traditional Chinese medicine composition for treating type II diabetes |
| 01/23/2013 | CN102293752B Preparation method of chitosan-carried capsaicin microsphere as well as microsphere and application of microsphere in weight reduction and sugar reduction |
| 01/23/2013 | CN102247420B Preparation method and application of eclipta extract |
| 01/23/2013 | CN102240343B Environment-friendly preparation method for high-ester catechin tea polyphenol |
| 01/23/2013 | CN102218113B Medicinal composition for reducing blood sugar and method for preparing same |
| 01/23/2013 | CN102191153B Burdock-water caltrop pulp health wine and production method thereof |
| 01/23/2013 | CN101973922B Atorvastatin semi-strontium salt polymorphs as well as preparation and application thereof as HMG-CoA enzyme inhibitor |
| 01/23/2013 | CN101926841B Total flavonoids of herba lycopi in botanical medicine for treating cardiovascular disease and preparation method thereof |
| 01/23/2013 | CN101869161B Lucid ganoderma weight-reducing tea with function of invigorating spleen and preparation method thereof |